Abstract
Rationale
Evidence suggests that recreational users of (±)3,4-methylenedioxymethamphetamine HCl (MDMA, “ecstasy”) have cognitive and behavioral deficits and show increased impulsivity consistent with 5-hydroxytryptamine (5-HT) neurotoxicity. MDMA effects on impulsivity in users are difficult to establish being confounded by polydrug use and individual predisposition to impulsivity or behavioral inhibition.
Objective
We previously observed a long-term anxiolytic effect of a neurotoxic dose of MDMA on elevated plus maze behavior in Dark Agouti (DA) rats while other strains were reported to show anxiogenesis. We have now examined whether MDMA influences impulsivity producing disinhibited behavior interpretable as anxiolysis.
Methods
Impulsivity was measured using an operant visuospatial discrimination procedure. Male DA rats (n=24) were trained to lever press for food reward in response to a light-stimulus and subsequently required to withhold responding. Correct responses, premature responses, and response latencies were used as measures of accuracy and impulsivity. Trained rats were administered MDMA (5 mg/kg, i.p. at 3-h intervals to a total of three injections). Performance was measured at 3 h and 7, 27, 49, and 80 days posttreatment.
Results
There was a short-term effect of MDMA on the percentage of correct responses at 3 h and day 1 with recovery to control levels by days 7–8 and no significant long-term changes up to day 80. There was no effect of MDMA on premature responses on any of the days measured. MDMA reduced cortical 5-HT content (MDMA 363±14 ng/g and control 440±10 ng/g tissue).
Conclusion
These results suggest that impulsivity may not be directly altered by MDMA despite serotonergic neurotoxicity.
Similar content being viewed by others
References
Balogh B, Molnar E, Jakus R, Olverman HJ, Kelly PAT, Kantor S, Bagdy G (2004) Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology 173:296–309
Battaglia G, Brooks BP, Kulsakdinum C, Desouza EB (1988) Pharmacologic profile of MDMA (3,4-Methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 149(1–2):159–163
Bizot JC, Le Bihan C, Puech AJ, Hamon M, Thiebot MH (1999) Serotonin and tolerance to delay of reward in rats. Psychopharmacology 146:400–412
Butler GKL, Montgomery AMJ (2004) Impulsivity, risk taking and recreational ‘ecstasy’ (MDMA) use. Drug Alcohol Depend 76:55–62
Chudasama Y, Passetti F, Rhodes SEV, Lopian D, Desai A, Robbins TW (2003) Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146:105–119
Colado MI, O’Shea E, Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173:249–263
Denk F, Walton ME, Jennings KA, Sharp T, Rushworth MFS, Bannerman DM (2005) Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. Psychopharmacology 179:587–596
Gamma A, Brandeis D, Brandeis R, Vollenweider FX (2005) The P3 in ‘ecstasy’ polydrug users during response inhibition and execution. J Psychopharmacol 19:504–512
Gerbing DW, Ahadi SA, Patton JH (1987) Toward a conceptualization of impulsivity—components across the behavioral and self-report domains. Multivariate Behav Res 22:357–379
Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719–725
Green AR, McGregor IS (2002) On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. Psychopharmacology 164:448–450
Green AR, Mechan AO, Elliott JM, O’Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol Rev 55:463–508
Green AR, O’Shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures Br J Pharmacol 146:306–312
Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D (2004) Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75:135–147
Hanson KL, Luciana M (2004) Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychol Med 34:229–246
Malle BF, Neubauer AC (1991) Impulsivity, reflection, and questionnaire response latencies-no evidence for a broad impulsivity trait. Pers Individ Differ 12:865–871
McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±) 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)—a controlled study in humans. Neuropsychopharmacology 10:129–138
McCann UD, Szabo A, Scheffel U, Dannals RF, Ricaurte GA (1998) Neurotoxic effects in human brains after use of 3,4-methylenedioxymethamphetamine (“ecstasy”) viewed by positron emission tomography. Lancet 352:1433–1437
McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ (2003) Increased anxiety 3 months after brief exposure to MDMA (‘ecstasy’) in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28:1472–1484
Mechan AO, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR (2002a) A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology 159:167–175
Mechan AO, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR (2002b) A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus maze, open field apparatus and activity meters, and their response to diazepam. Psychopharmacology 159:188–195
Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J (2001) The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 21:193–198
Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264
O’Shea E, Granados R, Esteban B, Colado MI, Green AR (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (‘ecstasy’). Neuropharmacology 37:919–926
O’Shea E, Orio L, Escobedo I, Sanchez V, Camarero J, Green AR, Colado MI (2006) MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature Br J Pharmacol DOI 10.1038/sj.bjp.0706783
Parrott AC (2002) Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71:837–844
Parrott AC, Sisk E, Turner JJD (2000) Psychobiological problems in heavy ‘ecstasy’ (MDMA) polydrug users. Drug Alcohol Depend 60:105–110
Petry NM (2001) Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 63:29–38
Piper BJ, Fraiman JB, Meyer JS (2005) Repeated MDMA (“ecstasy”) exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention and serotonin transporter binding. Dev Psychobiol 47:145–157
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott A (2001) Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study. Hum Psychopharmacol 16:619–625
Schifano F, Di Furia L, Forza C, Minicuci N, Bricolo R (1998) MDMA (‘ecstasy’) consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52:85–90
Schmidt CJ, Taylor VL (1987) Depression of rat-brain tryptophan-hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 36(23):4095–4102
Sher KJ, Trull TJ (1994) Personality and disinhibitory psychopathology-alcoholism and antisocial personality disorder. J Abnorm Psychol 103:92–102
Sher KJ, Bartholow BD, Wood MD (2000) Personality and substance use disorders: a prospective study. J Consult Clin Psychol 68:818–829
Semple SJ, Zians J, Grant I, Patterson TL (2005) Impulsivity and methamphetamine use. J Subst Abuse Treat 29:85–93
Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt, A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167:85–96
Travers KR, Lyvers M (2005) Mood and impulsivity of recreational ecstasy users in the week following a “rave.” Addiction Research and Theory 13:43–52
Verkes RJ, Gijsman HJ, Pieters MSM, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJM, de Bruin D, Van de Wijngaart G, Van Gerven JMA, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196–202
Weir E (2000) Raves: a review of the culture, the drugs and the prevention of harm. CMAJ 162:1843–1848
Yip JTH, Lee TMC (2005) Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology 179:620–628
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saadat, K.S., Elliott, J.M., Green, A.R. et al. High-dose MDMA does not result in long-term changes in impulsivity in the rat. Psychopharmacology 188, 75–83 (2006). https://doi.org/10.1007/s00213-006-0470-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-006-0470-8